Timoptol XE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Timoptol XE, covering 2011-09-05 to 2011-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients [Phase 4]